Quarterly Report

X4 Pharmaceuticals, Inc Filed 2023-08-10 Acc 0001628280-23-028897

Documents 1

2023-11-09 10-Q Quarterly Report
2023-08-14 S-3 Registration Statement
2023-08-14 S-8 Securities Offered to Employees in Benefit Plans
2023-08-11 4 Interim Chief Medical Officer sold 130,056 shares at $1.06 ($137,859)
2023-08-10 10-Q Quarterly Report
2023-08-10 8-K Results of operations
2023-05-04 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xfor-20230630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…